Showing papers for search query "Case+Study"+"FDA"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"

     Search term "Case+Study"+"FDA"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study
     Author ['AC Eifler', 'CS Thaxton']
     Venue Biomedical nanotechnology
     Year 2011
     Abstract Even at this stage, after extensive testing is already completed, approximately 10% of medications fail in Phase III trials (1). Success in  continue to report untoward side effects of the drug and manufacturers must submit periodic reports to the FDA describing any  2 Case Study
     Url https://link.springer.com/protocol/10.1007/978-1-61779-052-2_21


     Search term "Case+Study"+"FDA"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title A case study of personalized medicine
     Author ['SH Katsanis', 'G Javitt', 'K Hudson']
     Venue SCIENCE-NEW YORK THEN …
     Year 2008
     Abstract As described in this case study, this indirect approach has had no apparent effect on the availability of tests with questionable  health protection whether the test in ques- tion is based on a “test kit” or an LDT; FDA's review thus should not depend on the testing platform used
     Url https://www.researchgate.net/profile/Sara_Katsanis/publication/5464826_A_Case_Study_of_Personalized_Medicine/links/09e41507da4c453d8b000000/A-Case-Study-of-Personalized-Medicine.pdf


     Search term "Case+Study"+"FDA"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Pharmacogenomic data submissions to the FDA: non-clinical case studies
     Author ['JK Leighton', 'J DeGeorge', 'D Jacobson-Kram']
     Venue …
     Year 2004
     Abstract Discussion There was a strong consensus that neither example in the second case study rose to the  the fear being that such submissions could result in unnecessary additional testing (due to  this situation is not dis- similar from current practice when the FDA applies knowledge
     Url https://www.futuremedicine.com/doi/pdf/10.1517/14622416.5.5.507


     Search term "Case+Study"+"FDA"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Regulatory controls for direct-to-consumer genetic tests: a case study on how the FDA exercised its authority
     Author ['M Curnutte']
     Venue New Genetics and Society
     Year 2017
     Abstract medical (or government) paternalism and individuals' right to information about ourselves.” This debate is central to this case study and understanding the FDA's regulatory approach towards health-related DTC genetic tests. Advocates for DTC genetic testing promote the idea
     Url https://www.tandfonline.com/doi/abs/10.1080/14636778.2017.1354690


     Search term "Case+Study"+"FDA"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Evaluating oversight of human drugs and medical devices: a case study of the FDA and implications for nanobiotechnology
     Author ['J Paradise', 'AW Tisdale', 'RF Hall']
     Venue The Journal of Law …
     Year 2009
     Abstract elicitation are combined with the existing literature, case law, and regulations pro- viding an integrative historical case study approach  ratory and animal testing). This preclinical phase does not require prior notification of the FDA, but studies must follow good laboratory practices
     Url https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1748-720X.2009.00434.x


     Search term "Case+Study"+"FDA"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title A Case-Study Based Course on" Device Evaluation and FDA Approval"
     Author ['KOH Cardinal']
     Venue Biomedical and General Engineering
     Year 2008
     Abstract study: Progression through preclinical testing MIDTERM 6 Pilot and pivotal clinical studies Clinical studies: a physician's perspective 7 FDA approval: timelines, panels, and communication FDA enforcement and post-approval procedures 8 Case study: Progression through
     Url http://digitalcommons.calpoly.edu/cgi/viewcontent.cgi?article=1002&context=bmed_fac


     Search term "Case+Study"+"FDA"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products
     Author ['NL Kruhlak', 'JF Contrera', 'RD Benz']
     Venue Advanced drug delivery …
     Year 2007
     Abstract Predictive software validation: the OECD principles for (Q)SAR validation  3. A CDER case study. FDA/CDER operates a Computational Toxicology Consulting Service (CTCS) for the Agency that provides decision support information for FDA regulatory and research decisions
     Url https://www.sciencedirect.com/science/article/pii/S0169409X06002754


     Search term "Case+Study"+"FDA"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards
     Author ['MJ Malinowski', 'RJR Blatt']
     Venue Tul. L. Rev.
     Year 1996
     Abstract See OncorMed BRCAJ Testing Service, supra note 8, at 7 ("Currently, the FDA is not regulating the testing; the agency maintains that it has such authority but lacks the resources to review the technology or make and enforce new regulations for the field."). 11
     Url https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/tulr71&section=34


     Search term "Case+Study"+"FDA"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title … opposition to exclusive control over predictive breast cancer testing and the inherent implications for US patent law and public policy: A case study of the myriad …
     Author ['J Paradise']
     Venue Food & Drug LJ
     Year 2004
     Abstract Page 1. European Opposition to Exclusive Control Over Predictive Breast Cancer Testing and the Inherent Implications for US Patent Law and Public Policy: A Case Study of the Myriad Genetics' BRCA Patent Controversy JORDAN PARADISE* I. OVERVIEW
     Url https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/foodlj59&section=19


     Search term "Case+Study"+"FDA"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Novel personalized medicine technology: UGT1A1 testing for irinotecan as a case study
     Author ['SL Van Bebber', 'HL Keegan', 'KA Phillips', 'AM Issa']
     Venue NA
     Year 2006
     Abstract thus, we focus here on data particularly relevant to EDAPT and to this case study, but do not  what role the presumption of physician liability will play in the utilization of UGT1A1 testing. It is possible that because the US FDA has recommended dosing changes based on UGT1A1
     Url https://www.futuremedicine.com/doi/abs/10.2217/17410541.3.4.415

